stomach pain retatrutide STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD and Obesity Retatrutide is being talked about

At Balanced, we include peptide therapy in Phase 1 of most treatment plans because gut health is foundational

DSIP (Delta Sleep-Inducing Peptide) promotes deep delta-wave sleep, regulates circadian rhythms, and supports stress recovery

Glycine supports muscle preservation at the cellular level, but it cannot replace adequate total protein consumption

How Retatrutide Compares to Other GLP-1 Research Peptides Retatrutide (LY3437943) is a triple agonist that acts on the GLP-1, GIP, and glucagon receptors one more pathway than tirzepatide (GLP-1/GIP) and two more than semaglutide (GLP-1 only)

The market, both research and commercial, has seen a proliferation of GHK-Cu products

For persistent nausea, short-term antiemetic therapy may be considered, though with important restrictions: metoclopramide should be limited to a maximum 5-day course with appropriate dose limits as per MHRA guidance, whilst domperidone should only be used when benefits clearly outweigh risks, with assessment for cardiac risk factors and QT prolongation